Bactiguard Reports Q3 Adjusted EBITDA of SEK 20M
Bactiguard reported Q3 2026 adjusted EBITDA of SEK 20M and operating cash flow of SEK 14M. BD partnership revenues grew more than 30%, alongside double-digit Zimmer Biomet royalties.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.